Sundaram Multi Pap Ltd Upgraded to Sell on Improved Valuation Metrics

1 hour ago
share
Share Via
Sundaram Multi Pap Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 Oct 2026, driven primarily by a marked improvement in valuation metrics. Despite this upgrade, the company continues to face challenges in financial strength and long-term performance, reflecting a complex investment outlook for this micro-cap stock in the miscellaneous sector.
Sundaram Multi Pap Ltd Upgraded to Sell on Improved Valuation Metrics

Valuation Upgrade Spurs Rating Change

The most significant factor behind the upgrade is the shift in Sundaram Multi Pap Ltd’s valuation grade from "Attractive" to "Very Attractive". The company’s price-to-earnings (PE) ratio stands at a modest 14.45, considerably lower than many peers in the printing and stationery industry, such as Kokuyo Camlin with a PE of 34.61. Additionally, the price-to-book value is an appealing 0.56, signalling the stock is trading well below its book value, which often attracts value investors.

Enterprise value (EV) multiples also support this valuation case. The EV to EBITDA ratio is 12.16, and EV to capital employed is a notably low 0.64, indicating the company is priced cheaply relative to its earnings and capital base. The PEG ratio, which adjusts PE for earnings growth, is exceptionally low at 0.09, suggesting the stock is undervalued relative to its growth prospects. These valuation metrics collectively underpin the upgrade in the investment rating despite other concerns.

Financial Trend: Mixed Signals Amidst Growth

Financially, Sundaram Multi Pap Ltd has demonstrated some positive momentum in recent quarters. The company reported its highest quarterly net sales at ₹49.60 crores and a robust profit after tax (PAT) growth of 185.23% over the latest six months, reaching ₹1.27 crores. This earnings growth contrasts sharply with the stock’s poor price performance, which has declined by 43.98% over the past year.

However, the company’s return on capital employed (ROCE) remains weak at 1.98%, reflecting limited efficiency in generating returns from its capital base. The average EBIT to interest coverage ratio is a concerning 0.70, indicating the company struggles to comfortably service its debt obligations. These financial trends highlight a company in recovery but still grappling with underlying operational weaknesses.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

Quality Assessment Remains Weak

Despite the valuation improvement, the overall quality of Sundaram Multi Pap Ltd’s business remains a concern. The company’s average ROCE over recent years is a low 2.32%, signalling poor capital efficiency. This is compounded by consistent underperformance against benchmark indices such as the BSE500 and Sensex. Over the last three years, the stock has generated a cumulative return of -67.96%, while the Sensex gained 9.24% in the same period.

Long-term returns paint a similarly bleak picture, with a 10-year stock return of -74.76% compared to Sensex’s 158.06%. This persistent underperformance highlights structural challenges in the company’s business model and competitive positioning within the miscellaneous sector.

Technicals and Market Performance

From a technical perspective, Sundaram Multi Pap Ltd’s stock price has been under pressure. The current price is ₹1.07, down 0.93% on the day, hovering near its 52-week low of ₹1.04 and significantly below its 52-week high of ₹2.22. The stock’s recent weekly and monthly returns of -7.76% and -12.30% respectively, also lag behind the Sensex’s corresponding returns of -2.27% and -6.54%.

This weak price momentum reflects investor caution, likely driven by the company’s micro-cap status and ongoing fundamental challenges. The majority shareholding remains with non-institutional investors, which may limit liquidity and institutional interest.

Valuation Versus Peers

When compared with industry peers, Sundaram Multi Pap Ltd’s valuation stands out as very attractive. For instance, Kokuyo Camlin trades at a PE of 34.61 and EV to EBITDA of 14.57, while Linc is also rated very attractive with a PE of 16.27 and EV to EBITDA of 8.88. In contrast, Sundaram’s lower multiples and PEG ratio of 0.09 suggest it is undervalued relative to its earnings growth potential.

However, some peers such as Aztec Fluids are considered very expensive with a PE of 17.05 and PEG of 4.48, while others like Rotographics and Manugraph India are classified as risky due to extremely high or negative valuation multiples. This places Sundaram Multi Pap Ltd in a unique position of being a micro-cap with very attractive valuation but weak fundamentals.

Sundaram Multi Pap Ltd or something better? Our SwitchER feature analyzes this micro-cap Miscellaneous stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Investment Outlook

The upgrade to a Sell rating from Strong Sell reflects a nuanced view of Sundaram Multi Pap Ltd’s prospects. While valuation metrics have improved significantly, making the stock more attractive on a price basis, the company’s weak financial quality, poor capital efficiency, and consistent underperformance against benchmarks temper enthusiasm.

Investors should weigh the potential for value appreciation against the risks posed by the company’s operational challenges and limited debt servicing capacity. The stock’s micro-cap status and low liquidity add further layers of risk, suggesting that only risk-tolerant investors with a long-term horizon might consider exposure.

Overall, Sundaram Multi Pap Ltd remains a speculative investment with a Sell rating, reflecting cautious optimism driven by valuation but constrained by fundamental weaknesses.

Summary of Key Metrics

Valuation: Very Attractive (PE 14.45, P/B 0.56, EV/EBITDA 12.16, PEG 0.09)
Financial Trend: Positive quarterly sales and PAT growth but weak ROCE (1.98%) and interest coverage (0.70)
Quality: Poor long-term returns and capital efficiency (average ROCE 2.32%)
Technicals: Weak price momentum, trading near 52-week lows with negative returns over multiple timeframes

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News